DNMT1 and myeloid neoplasm: DNMT1-depletion terminates malignant self-replication but maintains normal hematopoietic stem cell self-replication [3–12]—a vital therapeutic index when treating myeloid malignancies, since normal hematopoiesis is needed to reverse low blood counts, the cause of morbidity and death.